CTI BioPharma Corp.
CTI BioPharma Corp. (CTIC) Stock Overview
Explore CTI BioPharma Corp.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.2B
P/E Ratio
-11.46
EPS (TTM)
$-0.54
ROE
13.18%
CTIC Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of CTI BioPharma Corp. (CTIC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $14.11.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -11.46 and a market capitalization of 1.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.